May 10th 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
April 30th 2024
Your daily dose of the clinical news you may have missed.
April 22nd 2024
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
March 29th 2024
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
March 19th 2024
The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.
New MMR Vaccine Ready for Fall: How Will it Be Different?
The GSK MMR vaccine Priorix is the first new MMR shot to be available since the Merck immunization was approved in 1971. Similar? Different? Find out.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 13, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 12, 2022
Newer Omicron Subvariants Evade Neutralizing Antibodies from Vaccination and Prior Infection, Says New Research
Findings showed neutralizing antibody responses to BA.4 and BA.5 subvariants were approximately 20-fold lower than to the original WA1/2020 strain.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 30, 2022
FDA Recommends COVID-19 Booster Doses Optimized for Omicron Variant
The FDA recommended on Thursday the inclusion of a SARS-CoV-2 Omicron component in COVID-19 vaccine booster doses.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 28, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 27, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 22, 2022
Merck & Co 21-valent Pneumococcal Conjugate Vaccine Ready for Phase III
The 21-valent pneumococcal conjugate vaccine targets 85% of invasive pneumococcal disease in adults aged ≥65 years; 8 serotypes are exclusive to this vaccine, says Merck.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 17, 2022
FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children 6 Months and Up
The FDA authorized emergency use of Moderna and Pfizer-BioNTech's COVID-19 vaccines for use in children as young as 6 months old.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 15, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 9, 2022
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for Persons Aged 18 Years and Older
If EUA is granted, the Novavax COVID-19 vaccine would be the first protein-based COVID-19 vaccine available in the US.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 2, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 1, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 31, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 25, 2022
Monkeypox: What We Know About the Outbreak Now
The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.